Design of the randomized, controlled sequential staged treatment of emphysema with upper lobe predominance (STEP-UP) study

BMC Pulmonary Medicine

Volumn 14, Issue 1, 2014, Pages

  Valipour, Arschang ^a   Herth, Felix ^b   Eberhardt, Ralf ^b   Shah, Pallav L ^c,d,e   Gupta, Avina ^f   Barry, Robert ^f   Henne, Erik ^f   Bandyopadhyay, Sourish ^f   Snell, Greg ^g  

^a Department of Respiratory and Critical Care Medicine Ludwig Boltzmann Institute for COPD Otto Wagner Hospital   (Australia)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e CHELSEA AND WESTMINSTER HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^f Uptake Medical Corp   (United States)

^g MONASH UNIVERSITY   (Australia)

Author keywords

Emphysema; Lung volume reduction; STEP UP; Vapour ablation

Indexed keywords

ABLATION THERAPY; ADULT; AGED; ARTICLE; BODY MASS; COMPARATIVE STUDY; CONTROLLED STUDY; DAILY LIFE ACTIVITY; EMPHYSEMA; FOLLOW UP; FORCED EXPIRATORY VOLUME; HUMAN; LUNG RESECTION; LUNG VOLUME; MAJOR CLINICAL STUDY; OPEN STUDY; OUTCOME ASSESSMENT; OXYGEN THERAPY; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL; RESIDUAL VOLUME; SCREENING TEST; ST. GEORGE RESPIRATORY QUESTIONNAIRE; TOTAL LUNG CAPACITY; UPPER LOBE PREDOMINANT EMPHYSEMA; ADVERSE EFFECTS; COMPLICATION; DYSPNEA; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; PROCEDURES; PULMONARY EMPHYSEMA;

ABLATION TECHNIQUES; ADULT; AGED; DYSPNEA; FORCED EXPIRATORY VOLUME; HUMANS; MIDDLE AGED; PNEUMONECTOMY; PULMONARY EMPHYSEMA; RESEARCH DESIGN; RESIDUAL VOLUME;

EID: 84924024504     PISSN: None     EISSN: 14712466     Source Type: Journal    
DOI: 10.1186/1471-2466-14-190     Document Type: Article

References (24)

1. Mathers C, Doris Ma F, Boerma JT: The Global Burden of Disease: 2004 Update. Geneva, Switzerland: World Health Organization; 2008.
2. Fishman A, Martinez F, Naunheim K, Piantadosi S, Wise R, Ries A, Weinmann G, Wood DE, National Emphysema Treatment Trial Research Group: A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 2003,348(21):2059-2073.
3. DeCamp MM, Blackstone EH, Naunheim KS, Krasna MJ, Wood DE, Meli YM, McKenna RJ Jr, NETT Research Group: Patient and surgical factors influencing air leak after lung volume reduction surgery: lessons learned from the national emphysema treatment trial. Ann Thorac Surg 2006,82(1):197-207. 10.1016/j.athoracsur.2006.02.050
4. Naunheim KS, Wood DE, Mohsenifar Z, Sternberg AL, Criner GJ, DeCamp MM, Deschamps CC, Martinez FJ, Sciurba FC, Tonascia J, Fishman AP: Long-term follow-up of patients receiving lung-volume-reduction surgery versus medical therapy for severe emphysema by the national emphysema treatment trial research group. Ann Thorac Surg 2006,82(2):431-443. 10.1016/j.athoracsur.2006.05.069
5. Kesten S, Anderson JC, Tuck SA: Rationale for the development and the mechanism of action of endoscopic thermal vapour ablation (InterVapour) for the treatment of emphysema. J Bronchology Interv Pulmonol 2012,19(3):237-245. 10.1097/LBR.0b013e31826137bc
6. Sciurba FC, Ernst A, Herth FJ, Strange C, Criner GJ, Marquette CH, Kovitz KL, Chiacchierini RP, Goldin J, McLennan G: A randomized study of endobronchial valves for advanced emphysema. N Engl J Med 2010, 363:1233-1244. 10.1056/NEJMoa0900928
7. Shah PL, Slebos DJ, Cardoso PF, Cetti E, Voelker K, Levine B, Russell ME, Goldin J, Brown M, Cooper JD, Sybrecht GW, EASE trial study group: Bronchoscopic lung-volume reduction with Exhale airway stents for emphysema (EASE trial): randomised, sham-controlled, multicentre trial. Lancet 2011, 378:997-1005. 10.1016/S0140-6736(11)61050-7
8. Shah PL, Zoumot Z, Singh S, Bicknell SR, Ross ET, Quiring J, Hopkinson NS, Kemp SV: Endobronchial coils for the treatment of severe emphysema with hyperinflation (RESET): a randomised controlled trial. Lancet Respir Med 2013, 1:233-240. 10.1016/S2213-2600(13)70047-X
9. Snell G, Herth FJ, Hopkins P, Baker KM, Witt C, Gotfried MH, Valipour A, Wagner M, Stanzel F, Egan JJ, Kesten S, Ernst A: Bronchoscopic thermal vapour ablation therapy in the management of heterogeneous emphysema. Eur Respir J 2012,39(6):1326-1333. 10.1183/09031936.00092411
10. Herth FJ, Ernst A, Baker KM, Egan JJ, Gotfried MH, Hopkins P, Stanzel F, Valipour A, Wagner M, Witt C, Kesten S, Snell G: Characterization of outcomes 1 year after endoscopic thermal vapor ablation for patients with heterogeneous emphysema. Int J Chron Obstruct Pulmon Dis 2012, 7:397.
11. Gompelmann D, Eberhardt R, Ernst A, Hopkins P, Egan J, Stanzel F, Valipour A, Wagner M, Witt C, Baker KM, Gotfried MH, Kesten S, Snell G, Herth FJ: The localized inflammatory response to bronchoscopic thermal vapor ablation. Respiration 2013,86(4):324-331. 10.1159/000354175
12. Anile M, Diso D, Venuta F: Assessment of intraparenchymal lung collateral ventilation. Thorax 2012,67(12):1111-1111.
13. Henderson R, Horsfield K, Cumming G: Intersegmental collateral ventilation in the human lung. Respir Physiol 1968,6(1):128-134. 10.1016/0034-5687(68)90022-4
14. Gompelmann D, Heussel CP, Eberhardt R, Snell G, Hopkins P, Baker K, Witt C, Valipour A, Wagner M, Stanzel F, Egan J, Ernst A, Kesten S, Herth FJ: Efficacy of bronchoscopic thermal vapor ablation and lobar fissure completeness in patients with heterogeneous emphysema. Respiration 2012,83(5):400-406. 10.1159/000336239
15. Jr MK, Robert J, Brenner M, Fischel RJ, Gelb AF: Should lung volume reduction for emphysema be unilateral or bilateral? J Thorac Cardiovasc Surg 1996,112(5):1331-1339. 10.1016/S0022-5223(96)70148-4
16. 1 change following lung volume reduction surgery. CHEST J 1998,113(3):652-659. 10.1378/chest.113.3.652
17. Russi EW, Bloch KE, Weder W: Functional and morphological heterogeneity of emphysema and its implication for selection of patients for lung volume reduction surgery. Eur Respir J 1999,14(1):230-236. 10.1034/j.1399-3003.1999.14a39.x
18. Becker MD, Berkmen YM, Austin JH, Mun IK, Romney BM, Rozenshtein A, Jellen PA, Yip CK, Thomashow B, Ginsburg ME: Lung volumes before and after lung volume reduction surgery: quantitative CT analysis. Am J Respir Crit Care Med 1998,157(5):1593-1599. 10.1164/ajrccm.157.5.9706066
19. Brenner M, McKenna RJ Jr, Chen JC, Serna DL, Powell LL, Gelb AF, Fischel RJ, Wilson AF: Relationship between amount of lung resected and outcome after lung volume reduction surgery. Ann Thorac Surg 2000,69(2):388-393. 10.1016/S0003-4975(99)01339-9
20. Sanchez PG, Kucharczuk JC, Su S, Kaiser LR, Cooper JD: National emphysema treatment trial redux: accentuating the positive. J Thorac Cardiovasc Surg 2010,140(3):564-572. 10.1016/j.jtcvs.2010.03.050
21. Gould GA, MacNee W, McLean A, Warren PM, Redpath A, Best JJ, Lamb D, Flenley DC: CT measurements of lung density in life can quantitate distal airspace enlargement-an essential defining feature of human emphysema. Am Rev Respir Dis 1988,137(2):380-392. 10.1164/ajrccm/137.2.380
22. Anderson JC, Norma L, Tuck SA: The impact of emphysema heterogeneity on the efficacy of lung volume reduction surgery: a retrospective analysis of the NETT study data. CHEST J 2010, 138.4_MeetingAbstracts:647A-647A.
23. Group NETTR: Patients at high risk of death after lung-volume-reduction surgery. N Engl J Med 2001,345(15):1075.
24. Criner GJ, Cordova F, Sternberg AL, Martinez FJ: The national emphysema treatment trial (NETT) part II: lessons learned about lung volume reduction surgery. Am J Respir Crit Care Med 2011,184(8):881-893. 10.1164/rccm.201103-0455CI